Safety, effectiveness, and cost effectiveness of long acting versus intermediate acting insulin for...
Safety, effectiveness, and cost effectiveness of long acting versus intermediate acting insulin for patients with type 1 diabetes: systematic review and network meta-analysis
About this item
Full title
Author / Creator
Tricco, Andrea C , Ashoor, Huda M , Antony, Jesmin , Beyene, Joseph , Veroniki, Areti Angeliki , Isaranuwatchai, Wanrudee , Harrington, Alana , Wilson, Charlotte , Tsouros, Sophia , Soobiah, Charlene , Yu, Catherine H , Hutton, Brian , Hoch, Jeffrey S , Hemmelgarn, Brenda R , Moher, David , Majumdar, Sumit R and Straus, Sharon E
Publisher
England: British Medical Journal Publishing Group
Journal title
Language
English
Formats
Publication information
Publisher
England: British Medical Journal Publishing Group
Subjects
More information
Scope and Contents
Contents
Objective To examine the safety, effectiveness, and cost effectiveness of long acting insulin for type 1 diabetes. Design Systematic review and network meta-analysis. Data sources Medline, Cochrane Central Register of Controlled Trials, Embase, and grey literature were searched through January 2013. Study selection Randomized controlled trials or n...
Alternative Titles
Full title
Safety, effectiveness, and cost effectiveness of long acting versus intermediate acting insulin for patients with type 1 diabetes: systematic review and network meta-analysis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4199252
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4199252
Other Identifiers
ISSN
0959-8138,1756-1833
E-ISSN
1756-1833
DOI
10.1136/bmj.g5459
